| scholarly article | Q13442814 |
| P2093 | author name string | Jian Zhang | |
| Liang Tang | |||
| Wei Dong | |||
| Wen Yang | |||
| Yan Lin | |||
| Chao Wang | |||
| Meng-Chao Wu | |||
| Zhong Li | |||
| Hong-Yang Wang | |||
| Liang Hu | |||
| Tao Luo | |||
| Qiong Liu | |||
| Yu-Qiong Li | |||
| Hui-Lu Zhang | |||
| Fu-Quan Wu | |||
| He-Xin Yan | |||
| Le-Xing Yu | |||
| Shan-Shan Zou | |||
| Long-Yi Zheng | |||
| Ya-Qin He | |||
| P2860 | cites work | Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production | Q29614596 |
| Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control | Q29616465 | ||
| EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features | Q30493364 | ||
| Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesis | Q33344462 | ||
| The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. | Q33929406 | ||
| The origin and liver repopulating capacity of murine oval cells | Q34582398 | ||
| Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? | Q34988085 | ||
| Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling | Q36497297 | ||
| WNT/beta-catenin signaling in liver health and disease | Q36804161 | ||
| Liver cancer stem cells | Q36835025 | ||
| Deregulated direct targets of the hepatitis B virus (HBV) protein, HBx, identified through chromatin immunoprecipitation and expression microarray profiling | Q37372165 | ||
| Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis | Q37621008 | ||
| Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway | Q39645695 | ||
| Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2. | Q39656536 | ||
| Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells | Q39976254 | ||
| High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. | Q39997004 | ||
| Identification and characterization of tumorigenic liver cancer stem/progenitor cells | Q40119609 | ||
| CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity | Q40186273 | ||
| Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. | Q40869986 | ||
| Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma | Q41548933 | ||
| Oval cell numbers in human chronic liver diseases are directly related to disease severity. | Q42050840 | ||
| Intermediate hepatobiliary cells predict an increased risk of hepatocarcinogenesis in patients with hepatitis C virus-related cirrhosis. | Q44410161 | ||
| Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells. | Q44706836 | ||
| 2-acetylaminofluorene dose-dependent differentiation of rat oval cells into hepatocytes: confocal and electron microscopic studies | Q44880267 | ||
| Direct effects of interleukin-6 on liver progenitor oval cells in culture | Q45156962 | ||
| Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. | Q46615053 | ||
| Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. | Q46913797 | ||
| Wnt/beta-catenin signaling mediates oval cell response in rodents | Q46955919 | ||
| Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver | Q47835382 | ||
| A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells | Q50115050 | ||
| Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. | Q52580893 | ||
| HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. | Q53370903 | ||
| Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. | Q53449416 | ||
| Cancer stem cells | Q80312237 | ||
| Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis | Q82294435 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| P304 | page(s) | 108-120 | |
| P577 | publication date | 2011-12-06 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice | |
| P478 | volume | 55 |
| Q36544739 | A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway |
| Q55472434 | A pivotal role of BEX1 in liver progenitor cell expansion in mice. |
| Q58769412 | Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model |
| Q36743804 | Activin A-Smad Signaling Mediates Connective Tissue Growth Factor Synthesis in Liver Progenitor Cells |
| Q34993913 | Adult hepatic cavernous hemangioma with highly elevated α-fetoprotein: A case report and review of the literature |
| Q38082388 | An update on viral association of human cancers |
| Q92733397 | Aquaporin 3 maintains the stemness of CD133+ hepatocellular carcinoma cells by activating STAT3 |
| Q37327771 | Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling |
| Q26772338 | Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma |
| Q40744258 | C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties. |
| Q33618740 | C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway. |
| Q39310264 | C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. |
| Q37675494 | Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma. |
| Q38125450 | Clinical significance of occult hepatitis B infection in progression of liver disease and carcinogenesis |
| Q90090343 | Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver |
| Q55053545 | Distinctiveness in virological features and pathogenic potentials of subgenotypes D1, D2, D3 and D5 of Hepatitis B virus. |
| Q34467228 | Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy. |
| Q91907148 | Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis |
| Q55420922 | Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx. |
| Q40629212 | Evidence of Hepatitis B Virus Infection in Cancer and Noncancer Stem Cells Associated with Human Hepatocellular Carcinoma |
| Q42181540 | Expression of EpCAM increases in the hepatitis B related and the treatment-resistant hepatocellular carcinoma. |
| Q39196702 | Extracellular Vesicles Deliver Host and Virus RNA and Regulate Innate Immune Response |
| Q54490308 | Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. |
| Q36372435 | Hepatitis B Virus X Protein Upregulates hELG1/ ATAD5 Expression through E2F1 in Hepatocellular Carcinoma |
| Q38690987 | Hepatitis B Virus X and Regulation of Viral Gene Expression |
| Q34915498 | Hepatitis B virus X (HBx) play an anti-apoptosis role in hepatic progenitor cells by activating Wnt/β-catenin pathway |
| Q38989340 | Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP. |
| Q90412307 | Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation |
| Q37744990 | Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma |
| Q31073665 | Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis |
| Q92669979 | Hyperactivation of IL-6/STAT3 pathway leaded to the poor prognosis of post-TACE HCCs by HIF-1α/SNAI1 axis-induced epithelial to mesenchymal transition |
| Q89598028 | Impact of the Interaction of Hepatitis B Virus with Mitochondria and Associated Proteins |
| Q38435353 | Integrated analysis of microRNA and mRNA expression profiles in HBx-expressing hepatic cells |
| Q39471805 | Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma. |
| Q86893402 | Interleukin-22, liver progenitor cells, and liver cancer |
| Q64080308 | Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review |
| Q47215507 | Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications |
| Q41233768 | Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance |
| Q34259112 | Role of liver stem cells in hepatocarcinogenesis |
| Q55288642 | Role of nonresolving inflammation in hepatocellular carcinoma development and progression. |
| Q46436038 | SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases |
| Q27000742 | STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver |
| Q64915857 | Serum hepatitis B viral (HBV) DNA is a predictive biomarker for survival in non-small cell lung cancer patients with chronic HBV infection. |
| Q37309060 | Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma. |
| Q26773251 | Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma |
| Q39032523 | Smad6 suppresses the growth and self-renewal of hepatic progenitor cells |
| Q83600789 | TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p |
| Q92276503 | TLX3 repressed SNAI1-induced epithelial-mesenchymal transition by directly constraining STAT3 phosphorylation and functionally sensitized 5-FU chemotherapy in hepatocellular carcinoma |
| Q40154855 | The C-terminus domain of the hepatitis B virus x protein stimulates the proliferation of mouse foetal hepatic progenitor cells, although it is not required for the formation of spheroids |
| Q90398809 | The Cancer Stem Cell in Hepatocellular Carcinoma |
| Q38823884 | The potential role of liver stem cells in initiation of primary liver cancer |
| Q28288613 | The role of the hepatitis viruses in cholangiocarcinoma |
| Q91804872 | The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma |
| Q96304826 | Thyroid Hormone in Hepatocellular Carcinoma: Cancer Risk, Growth Regulation, and Anticancer Drug Resistance |
| Q27692697 | Turning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives. |
| Q37997455 | Xenobiotic-induced liver injury and fibrosis |
Search more.